chr5-14143738-A-G

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2

The NM_007118.4(TRIO):ā€‹c.13A>Gā€‹(p.Ser5Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000592 in 979,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000090 ( 0 hom., cov: 31)
Exomes š‘“: 0.000054 ( 0 hom. )

Consequence

TRIO
NM_007118.4 missense

Scores

2
1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0170
Variant links:
Genes affected
TRIO (HGNC:12303): (trio Rho guanine nucleotide exchange factor) This gene encodes a large protein that functions as a GDP to GTP exchange factor. This protein promotes the reorganization of the actin cytoskeleton, thereby playing a role in cell migration and growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TRIO. . Gene score misZ 5.3161 (greater than the threshold 3.09). Trascript score misZ 4.6722 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, autosomal dominant 40, syndromic intellectual disability, intellectual developmental disorder, autosomal dominant 63, with macrocephaly, micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.077849686).
BS2
High AC in GnomAd4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TRIONM_007118.4 linkuse as main transcriptc.13A>G p.Ser5Gly missense_variant 1/57 ENST00000344204.9 NP_009049.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TRIOENST00000344204.9 linkuse as main transcriptc.13A>G p.Ser5Gly missense_variant 1/571 NM_007118.4 ENSP00000339299 P1O75962-1
TRIOENST00000698541.1 linkuse as main transcriptc.13A>G p.Ser5Gly missense_variant 1/37 ENSP00000513786
TRIOENST00000502816.1 linkuse as main transcriptn.37A>G non_coding_transcript_exon_variant 1/52
TRIOENST00000505971.5 linkuse as main transcriptn.37A>G non_coding_transcript_exon_variant 1/43

Frequencies

GnomAD3 genomes
AF:
0.0000897
AC:
13
AN:
144880
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000248
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00178
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00329
Gnomad NFE
AF:
0.0000612
Gnomad OTH
AF:
0.000500
GnomAD4 exome
AF:
0.0000539
AC:
45
AN:
834598
Hom.:
0
Cov.:
29
AF XY:
0.0000519
AC XY:
20
AN XY:
385700
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00346
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000197
Gnomad4 OTH exome
AF:
0.000437
GnomAD4 genome
AF:
0.0000897
AC:
13
AN:
144880
Hom.:
0
Cov.:
31
AF XY:
0.0000852
AC XY:
6
AN XY:
70400
show subpopulations
Gnomad4 AFR
AF:
0.0000248
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00178
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000612
Gnomad4 OTH
AF:
0.000500
Alfa
AF:
0.000169
Hom.:
0
Bravo
AF:
0.0000945

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2023The c.13A>G (p.S5G) alteration is located in exon 1 (coding exon 1) of the TRIO gene. This alteration results from a A to G substitution at nucleotide position 13, causing the serine (S) at amino acid position 5 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
17
DANN
Benign
0.87
DEOGEN2
Benign
0.049
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.083
N
LIST_S2
Benign
0.25
T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.078
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.059
Sift
Pathogenic
0.0
D
Polyphen
0.14
B
Vest4
0.17
MutPred
0.19
Loss of glycosylation at S5 (P = 0.0011);
MVP
0.37
MPC
0.77
ClinPred
0.18
T
GERP RS
-0.10
Varity_R
0.19
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1052849519; hg19: chr5-14143847; API